Uni-Bio Science Group Announces 2024 Interim Results
- Written by Reporters
Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4MFurther Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets HONG KONG SAR - EQS Newswire - 28 August 2024 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred...
Read more: Uni-Bio Science Group Announces 2024 Interim Results

